Sequential endoscopic ultrasound identifies predictive variables for relapse-free follow-up after neoadjuvant chemotherapy in gastric cancer

References

• Robert-Koch-Institute. Cancer in Germany. www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2015/krebs_in_deutschland_2015.pdf;jsessionid=D638C17DF313A6089B308C38F7FF857C.2_cid298?__blob=publicationFile
   Google Scholar
• Warneke VS, Behrens HM, Hartmann J, et al. Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal for a new staging system. JCO. 2011;29:2364–2371.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.
   PubMed Web of Science ®Google Scholar
• Ychou M, Goige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. JCO. 2011;29:1715–1721.
   PubMed Web of Science ®Google Scholar
• Moehler M, Al-Batran SE, Andus T, et al. German S3-guideline “diagnosis and treatment of esophagogastric cancer”. Z Gastroenterol. 2011;49:461–531.
   PubMed Web of Science ®Google Scholar
• Waddel T, Verheij M, Allum W, et al. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:iv57–iv63.
   Web of Science ®Google Scholar
• Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev. 2015;CD009944. DOI:10.1002/1465858.CD009944.pub2.
   Web of Science ®Google Scholar
• Spolverato G, Ejaz A, Kim Y, et al. Use of endoscopic ultrasound in the preoperative staging of gastric cancer: a multi-institutional study of the US gastric cancer collaborative. J Amer Coll Surg. 2015;220:48–56.
   PubMed Web of Science ®Google Scholar
• Heinzow HS, Seifert T, Tsepetonidis S, et al. Endoscopic ultrasound in staging esophageal cancer after neoadjuvant chemotherapy – results of a multicenter cohort. J Gastrointest Surg. 2013;17:1050–1057.
   PubMed Web of Science ®Google Scholar
• Jost C, Binke J, Schuller JC, et al. Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase II study by the Swiss group for clinical cancer research (SAKK 75/02). Gastrointest Endosc. 2010;71:1114–1121.
   PubMed Web of Science ®Google Scholar
• Chak A, Canto MI, Cooper GS, et al. Endsonographic assessment of multimodality therapy predicts survival of esophageal cancer patients. Cancer. 2000;88:1788–1795.
   PubMed Web of Science ®Google Scholar
• Hirata N, Kawamoto K, Ueyama T, et al. Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer. AJR Am J Roentgenol. 1997;169:485–491.
   PubMed Web of Science ®Google Scholar
• Shim CN, Song MK, Lee HS, et al. Prediction of survival by tumor area on endosonography after definitive chemoradiotherapy for locally advanced squamous cell carcinoma of the esophagus. Digestion. 2014;90:98–107.
   PubMed Web of Science ®Google Scholar
• Mesenas S, Vu C, McStay M, et al. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy. Dis Esophag. 2008;21:37–42.
   PubMed Web of Science ®Google Scholar
• Agarwal B, Swicher S, Ajani J, et al. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol. 2004;99:1258–1266.
   PubMed Web of Science ®Google Scholar
• Griffin JM, Reed CF, Denlinger CE. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer. Ann Thorac Surg. 2012;93:1855–1860.
   PubMed Web of Science ®Google Scholar
• Park SR, Lee JS, Kim CG, et al. Endoscopic ultrasound and computer tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer. 2008;112:2368–2376.
   PubMed Web of Science ®Google Scholar
• Guo T, Yao F, Yang AM, et al. Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy. Asia Pac J Clin Oncol. 2014;10:28–32.
   Web of Science ®Google Scholar
• Catalano MF, Sivak MV Jr, Rice T, et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–446.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Jenssen C, Ardiciacono PG, et al. Endoscopic ultrasound: elastographic lymph node evaluation. Endosc Ultrasound. 2015;4:176–190.
   PubMed Web of Science ®Google Scholar
• Barbour AP, Rozk NP, Gerdes H, et al. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg. 2007;205:593–601.
   PubMed Web of Science ®Google Scholar
• Juergensen C, Brand J, Nothnagel M, et al. Prognostic relevance of gastric cancer staging by endoscopic ultrasound. Surg Endosc. 2013;27:1124–1129.
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Franceschi D, Parra J, et al. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol. 2006;101:1216–1221.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Tanabe K, Nishikawa K, et al. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study. Ann Surg Oncol. 2014;21(Suppl. 3):S385–S389.
   PubMed Web of Science ®Google Scholar
• Schulz C, Kullmann F, Kunzmann V, et al. NeoFLOT: multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-very good response predominantly in patients with intestinal type tumors. Int J Cancer. 2015;137:678–685.
   PubMed Web of Science ®Google Scholar
• Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICION phase II trial. Lancet Oncol. 2007;9:797–805.
   Web of Science ®Google Scholar